Zhiyong Yu

Person

Wilmington, DE, US

People

Patents Grantslast 30 patents

Information Patent Grant
Fused pyrimidine derivatives as A2A/A2B inhibitors
- Patent number 11,873,304
- Issue date Jan 16, 2024
- Incyte Corporation
- Xiaozhao Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted pyrrolo[2,1-f][1,2,4]triazine compounds as JAK2 V617F i...
- Patent number 11,753,413
- Issue date Sep 12, 2023
- Incyte Corporation
- Zhiyong Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds as immunomodulators
- Patent number 11,718,605
- Issue date Aug 8, 2023
- Incyte Corporation
- Zhiyong Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors
- Patent number 11,673,894
- Issue date Jun 13, 2023
- Incyte Corporation
- Xiaozhao Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic compounds as immunomodulators
- Patent number 11,465,981
- Issue date Oct 11, 2022
- Incyte Corporation
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused pyrimidine derivatives as A2A / A2B inhibitors
- Patent number 11,168,089
- Issue date Nov 9, 2021
- Incyte Corporation
- Xiaozhao Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazopyridines and imidazopyrazines as LSD1 inhibitors
- Patent number 10,640,503
- Issue date May 5, 2020
- Incyte Corporation
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazopyridines and imidazopyrazines as LSD1 inhibitors
- Patent number 10,047,086
- Issue date Aug 14, 2018
- Incyte Corporation
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted imidazo[1,5-α]pyridines and imidazo[1,5-α]pyrazines as...
- Patent number 9,695,168
- Issue date Jul 4, 2017
- Incyte Corporation
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
FUSED PYRAZINE DERIVATIVES AS A2A / A2B INHIBITORS
- Publication number 20240360140
- Publication date Oct 31, 2024
- INCYTE CORPORATION
- Xiaozhao Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS
- Publication number 20230357255
- Publication date Nov 9, 2023
- INCYTE CORPORATION
- Xiaozhao Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS
- Publication number 20230114765
- Publication date Apr 13, 2023
- INCYTE CORPORATION
- Zhenwu Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20220194931
- Publication date Jun 23, 2022
- INCYTE CORPORATION
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED PYRAZINE DERIVATIVES AS A2A / A2B INHIBITORS
- Publication number 20220135570
- Publication date May 5, 2022
- INCYTE CORPORATION
- Xiaozhao Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRROLOTRIAZINE COMPOUNDS AS JAK2 V617F INHIBITORS
- Publication number 20210395257
- Publication date Dec 23, 2021
- INCYTE CORPORATION
- Zhiyong Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20210363137
- Publication date Nov 25, 2021
- INCYTE CORPORATION
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED PYRIMIDINE DERIVATIVES AS A2A / A2B INHIBITORS
- Publication number 20210261555
- Publication date Aug 26, 2021
- INCYTE CORPORATION
- Xiaozhao Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS
- Publication number 20210139485
- Publication date May 13, 2021
- INCYTE CORPORATION
- Xiaozhao Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20210115025
- Publication date Apr 22, 2021
- INCYTE CORPORATION
- Zhiyong Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20210107900
- Publication date Apr 15, 2021
- INCYTE CORPORATION
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20200325115
- Publication date Oct 15, 2020
- INCYTE CORPORATION
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20200283423
- Publication date Sep 10, 2020
- INCYTE CORPORATION
- Zhiyong Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED PYRAZINE DERIVATIVES AS A2A / A2B INHIBITORS
- Publication number 20200031835
- Publication date Jan 30, 2020
- INCYTE CORPORATION
- Xiaozhao Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED PYRIMIDINE DERIVATIVES AS A2A / A2B INHIBITORS
- Publication number 20190375752
- Publication date Dec 12, 2019
- INCYTE CORPORATION
- Xiaozhao Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS
- Publication number 20190292188
- Publication date Sep 26, 2019
- INCYTE CORPORATION
- Xiaozhao Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20190225601
- Publication date Jul 25, 2019
- INCYTE CORPORATION
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMIDAZOPYRIDINES AND IMIDAZOPYRAZINES AS LSD1 INHIBITORS
- Publication number 20190040058
- Publication date Feb 7, 2019
- INCYTE CORPORATION
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20180273519
- Publication date Sep 27, 2018
- INCYTE CORPORATION
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20180179179
- Publication date Jun 28, 2018
- INCYTE CORPORATION
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20180179197
- Publication date Jun 28, 2018
- INCYTE CORPORATION
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20180016260
- Publication date Jan 18, 2018
- INCYTE CORPORATION
- Zhiyong Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMIDAZOPYRIDINES AND IMIDAZOPYRAZINES AS LSD1 INHIBITORS
- Publication number 20170369487
- Publication date Dec 28, 2017
- INCYTE CORPORATION
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20170174671
- Publication date Jun 22, 2017
- INCYTE CORPORATION
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMIDAZOPYRIDINES AND IMIDAZOPYRAZINES AS LSD1 INHIBITORS
- Publication number 20160009712
- Publication date Jan 14, 2016
- INCYTE CORPORATION
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY

Person

Patents Grantslast 30 patents

Fused pyrimidine derivatives as A2A/A2B inhibitors

Substituted pyrrolo[2,1-f][1,2,4]triazine compounds as JAK2 V617F i...

Heterocyclic compounds as immunomodulators

Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors

Heterocyclic compounds as immunomodulators

Fused pyrimidine derivatives as A2A / A2B inhibitors

Imidazopyridines and imidazopyrazines as LSD1 inhibitors

Imidazopyridines and imidazopyrazines as LSD1 inhibitors

Substituted imidazo[1,5-α]pyridines and imidazo[1,5-α]pyrazines as...

Patents Applicationslast 30 patents

FUSED PYRAZINE DERIVATIVES AS A2A / A2B INHIBITORS

IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS

TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

FUSED PYRAZINE DERIVATIVES AS A2A / A2B INHIBITORS

PYRROLOTRIAZINE COMPOUNDS AS JAK2 V617F INHIBITORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

FUSED PYRIMIDINE DERIVATIVES AS A2A / A2B INHIBITORS

IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

FUSED PYRAZINE DERIVATIVES AS A2A / A2B INHIBITORS

FUSED PYRIMIDINE DERIVATIVES AS A2A / A2B INHIBITORS

IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

IMIDAZOPYRIDINES AND IMIDAZOPYRAZINES AS LSD1 INHIBITORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

IMIDAZOPYRIDINES AND IMIDAZOPYRAZINES AS LSD1 INHIBITORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

IMIDAZOPYRIDINES AND IMIDAZOPYRAZINES AS LSD1 INHIBITORS